Nephrocare Health Services Limited
597.30
INR
-3.70
(-0.62%)
Nephrocare Health Services Limited
BSE:NEPHROPLUS
(Bombay Stock Exchange)
Recent
price
597.30
P/E
ratio
78.63
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- Nephrocare Health Services Limited, operating under the brand name NephroPlus, is an India-based multinational healthcare services company specializing in comprehensive renal care and dialysis solutions. The company operates an extensive network of specialized standalone clinics, government-partnered centers, and hospital-based dialysis departments catering to individuals diagnosed with chronic kidney disease and end-stage renal disease. Nephrocare Health Services Limited delivers end-to-end renal care through an array of clinical and support services, including in-center conventional hemodialysis; single-use dialyzer hemodialysis; nocturnal and holiday hemodialysis; pediatric dialysis; home-based hemodialysis; peritoneal dialysis, comprising continuous ambulatory peritoneal dialysis and automated peritoneal dialysis; mobile dialysis units operated via its Dialysis on Wheels initiative; vascular access procedures and arteriovenous fistula maintenance; nephrologist tele-consultations and renal nutrition counseling; on-site diagnostic pathology testing; pharmacy dispensation for specialized nephrology consumables and pharmaceuticals; and professional healthcare education via the NephroPlus Dialysis Academy. The company delivers these services through direct-to-consumer centers, long-term public-private partnership frameworks with regional health authorities, and asset-light turnkey outsourcing agreements with multi-specialty hospital networks. In recent developments, Nephrocare Health Services Limited completed its initial public offering on the National Stock Exchange of India and the Bombay Stock Exchange, bolstering its capital base for global and domestic network expansion. The company has advanced its international inorganic growth strategy by acquiring Dialysis Center Almaty LLP in Kazakhstan and consolidating multiple renal clinic assets across the Philippines, while scaling major public-private partnership dialysis concessions commissioned by the Ministry of Health of the Republic of Uzbekistan. Additionally, the organization has broadened its home dialysis care footprint, introduced upgraded digital patient monitoring and clinical software systems, and scaled its proprietary RenAssure clinical quality protocols across its operational footprint. Founded in 2010, Nephrocare Health Services Limited is headquartered in Hyderabad, Telangana, India, and maintains clinical operations across India, the Philippines, Uzbekistan, Kazakhstan, and Nepal.